Funding Rounds
Hemab

Hemab Series A (2021, $55M)

Hemab

Treatments for genetic bleeding disorders.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $55.00M

Raised Date: 2021-01-01

Investors